Evidence map›Paper›PMID 32107391›Full record

ArticleScientific reports2020

Network modeling of patients' biomolecular profiles for clinical phenotype/outcome prediction.

Jessica Gliozzo, Paolo Perlasca, Marco Mesiti, Elena Casiraghi, Viviana Vallacchi, Elisabetta Vergani, Marco Frasca, Giuliano Grossi, Alessandro Petrini, Matteo Re and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. LanDis: the disease landscape explorer.European journal of human genetics : EJHG · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Jessica GliozzoAnacletoLab - Dipartimento di Informatica, Università degli Studi di Milano, Milan, 20133, Italy.
Paolo PerlascaAnacletoLab - Dipartimento di Informatica, Università degli Studi di Milano, Milan, 20133, Italy.
Marco MesitiAnacletoLab - Dipartimento di Informatica, Università degli Studi di Milano, Milan, 20133, Italy.
Elena CasiraghiAnacletoLab - Dipartimento di Informatica, Università degli Studi di Milano, Milan, 20133, Italy.ORCID http://orcid.org/0000-0003-2024-7572
Viviana VallacchiUnit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Elisabetta VerganiUnit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Marco FrascaAnacletoLab - Dipartimento di Informatica, Università degli Studi di Milano, Milan, 20133, Italy.
Giuliano GrossiAnacletoLab - Dipartimento di Informatica, Università degli Studi di Milano, Milan, 20133, Italy.
Alessandro PetriniAnacletoLab - Dipartimento di Informatica, Università degli Studi di Milano, Milan, 20133, Italy.
Matteo ReAnacletoLab - Dipartimento di Informatica, Università degli Studi di Milano, Milan, 20133, Italy.
Alberto PaccanaroRoyal Holloway, University of London, Centre for Systems and Synthetic Biology - Department of Computer Science, Egham, TW20 0EX, UK. alberto.paccanaro@rhul.ac.uk.
Giorgio ValentiniAnacletoLab - Dipartimento di Informatica, Università degli Studi di Milano, Milan, 20133, Italy. valentini@di.unimi.it.ORCID http://orcid.org/0000-0002-5694-3919
University of Milan · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITRoyal Holloway University of London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/F00964X/1
6 · The paper itself

Abstract

Methods for phenotype and outcome prediction are largely based on inductive supervised models that use selected biomarkers to make predictions, without explicitly considering the functional relationships between individuals. We introduce a novel network-based approach named Patient-Net (P-Net) in which biomolecular profiles of patients are modeled in a graph-structured space that represents gene expression relationships between patients. Then a kernel-based semi-supervised transductive algorithm is applied to the graph to explore the overall topology of the graph and to predict the phenotype/clinical outcome of patients. Experimental tests involving several publicly available datasets of patients afflicted with pancreatic, breast, colon and colorectal cancer show that our proposed method is competitive with state-of-the-art supervised and semi-supervised predictive systems. Importantly, P-Net also provides interpretable models that can be easily visualized to gain clues about the relationships between patients, and to formulate hypotheses about their stratification.

Indexed as

Gene Regulatory NetworksNeural Networks, ComputerAlgorithmsArtificial IntelligenceBreast NeoplasmsColorectal NeoplasmsComputational BiologyDatasets as TopicFemaleHumansIndividualityMalePancreatic NeoplasmsPhenotypePrognosisTranscriptome

Identifiers

PMID32107391
PMCPMC7046773
OpenAlexW3010511947

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.